Federal Circuit Summary -
Before Lourie, Chen, and Stoll. Appeal from the Patent Trial and Appeal Board.
Summary: A generic pharmaceutical company had standing to appeal the Board’s decision in an IPR that claims of a...more
1/16/2019
/ Appeals ,
Generic Drugs ,
Hatch-Waxman ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Trial and Appeal Board ,
Patent Validity ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Right To Appeal ,
Standing